Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 79Breast Neoplasms 7Neoplasms 6Prostate Adenocarcinoma 2Polycystic Ovary Syndrome 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leiomyoma 2Hodgkin Disease 2Uveal Melanoma 1Urogenital Neoplasms 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Prostatic Diseases 1Premenopausal Breast Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1PSA Level Greater Than Two 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Metabolic Syndrome 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphatic Metastasis 1Lower Urinary Tract Symptoms 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Gemcitabine 14Cisplatin 13Capecitabine 11Oxaliplatin 9Fluorouracil 9130-nm albumin-bound paclitaxel 9Paclitaxel 8pembrolizumab 7Ramucirumab 6Leucovorin 6Carboplatin 6Bevacizumab 6Albumin-Bound Paclitaxel 6Pemetrexed 4Nivolumab 4Irinotecan 4Everolimus 4Erlotinib Hydrochloride 4Docetaxel 4Cyclophosphamide 4trastuzumab deruxtecan 3Radiotherapy 3Afatinib 3zolbetuximab 2pralsetinib 2cabozantinib 2Trastuzumab 2Ipilimumab 2vosaroxin 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenocarcinoma × Leuprolide × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡